{
    "data": [
        {
            "id": "4557635",
            "title": "Clear Channel Outdoor reports Q4 results",
            "description": "<html><body><ul>\n<li>Clear Channel Outdoor <a href=\"https://seekingalpha.com/pr/20414807-clear-channel-outdoor-holdings-inc-reports-results-for-the-fourth-quarter-and-full-year-of\">press release</a>  (CCO): Q4 AFFO of $59.8M, up 62.4%</li>\n<li>Adjusted EBITDA $164M, up 13.6%</li>\n<li>Revenue of $461.5M (+8.2% Y/Y) <font color=\"green\"> beats by $12.43M</font>.</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557635-clear-channel-outdoor-reports-q4-results",
            "pub_date": "2026-02-26 19:20:48",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557508",
            "title": "Palvella Therapeutics stock rises on $200M share offering",
            "description": "<html><body><ul>\n<li>Palvella Therapeutics (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/PVLA\" title=\"Palvella Therapeutics, Inc.\">PVLA</a></span>) <a href=\"https://seekingalpha.com/pr/20414543-palvella-therapeutics-announces-pricing-of-upsized-public-offering\" target=\"_blank\" title=\" said \">said </a>it priced an upsized public offering of 1.6M shares at $125 per share.</li>\n<li>The company expects to raise about $200M before fees and expenses. Underwriters have a 30-day option to buy up to 240,000 additional shares at the same price.</li>\n<li>The offering is expected to close around February 27, 2026, pending customary conditions.</li>\n<li>Palvella (<a href=\"https://seekingalpha.com/symbol/PVLA\" title=\"Palvella Therapeutics, Inc.\">PVLA</a>) intends to use the net proceeds from this offering to support the development of its programs, including QTORIN rapamycin and QTORIN pitavastatin, and for working capital and other general corporate purposes, including research and development expenses.</li>\n<li>PVLA shares rose<span> 5%</span> premarket at <span>$135.05</span>.</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557508-palvella-therapeutics-stock-rises-on-200m-share-offering",
            "pub_date": "2026-02-26 19:20:48",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557632",
            "title": "BeiGene Non-GAAP EPS of $1.95 beats by $0.65, revenue of $1.5B beats by $50M",
            "description": "<html><body><ul>\n<li>BeiGene <a href=\"https://seekingalpha.com/pr/20414800-beone-medicines-announces-fourth-quarter-and-full-year-2025-financial-results-highlighting\">press release</a> (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/ONC\" title=\"BeOne Medicines AG\">ONC</a></span>): Q4 Non-GAAP EPS of $1.95 <span> beats by $0.65</span>.</li>\n<li>Revenue of $1.5B (+36.4% Y/Y) <span> beats by $50M</span>.</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557632-beigene-non-gaap-eps-of-1_95-beats-by-0_65-revenue-of-1_5b-beats-by-50m",
            "pub_date": "2026-02-26 19:15:35",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557634",
            "title": "ACI Worldwide GAAP EPS of $0.62 misses by $0.18, revenue of $1.76B beats by $1.29B",
            "description": "<html><body><ul>\n<li>ACI Worldwide <a href=\"https://seekingalpha.com/pr/20414809-aci-worldwide-inc-reports-double-digit-revenue-growth-for-full-year-ended-december-31-2025\">press release</a>  (ACIW): Q4  GAAP EPS of $0.62 <font color=\"red\"> misses by $0.18</font>.</li>\n<li>Revenue of $1.76B (+288.5% Y/Y) <font color=\"green\"> beats by $1.29B</font>.</li>\n<li>\"For the full year of 2026, we expect revenue growth to be in the 7% to 9% range on a constant currency basis, or in the range of $1.88 billion to $1.91 billion. We expect adjusted EBITDA to be in the range of $530 million to $550 million. For Q1 2026, we expect revenue to be between $405 million and $415 million and adjusted EBITDA of $88 million to $93 million.\" the company said.</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557634-aci-worldwide-gaap-eps-of-0_62-misses-by-0_18-revenue-of-1_76b-beats-by-1_29b",
            "pub_date": "2026-02-26 19:15:35",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557618",
            "title": "Primo Water Non-GAAP EPS of $0.26 beats by $0.06, revenue of $1.55B beats by $40M",
            "description": "<html><body><ul>\n<li>Primo Water <a href=\"https://seekingalpha.com/pr/20414784-primo-brands-reports-2025-fourth-quarter-and-full-year-results\">press release</a> (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/PRMB\" title=\"Primo Brands Corporation\">PRMB</a></span>): Q4 Non-GAAP EPS of $0.26 <span> beats by $0.06</span>.</li>\n<li>Revenue of $1.55B (+10.7% Y/Y) <span> beats by $40M</span>.</li>\n<li>Net sales increased 11.2% to $1.6 billion compared to $1.4 billion primarily driven by the inclusion of net sales attributable to Primo Water for the entire 2025 period due to the merger transaction, partially offset by a decrease in sales attributable to the sale of the production facility in<span> </span><span>Ontario, Canada</span><span> </span>in the first quarter of 2025.</li>\n<li> </li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557618-primo-water-non-gaap-eps-of-0_26-beats-by-0_06-revenue-of-1_55b-beats-by-40m",
            "pub_date": "2026-02-26 19:06:33",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557619",
            "title": "Millicom International Cellular S.A. reports Q4 results",
            "description": "<html><body><ul>\n<li>Millicom International Cellular S.A. <a href=\"https://seekingalpha.com/pr/20414813-millicom-tigo-q4-2025-earnings-release\">press release</a> (<span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/TIGO\" title=\"Millicom International Cellular S.A.\">TIGO</a></span></span>): Q4 Net profit attributable to company owners $252 million</li>\n<li>Revenue of $1.65B (+15.4% Y/Y) <span> beats by $110M</span>.</li>\n<li> </li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557619-millicom-international-cellular-sa-reports-q4-results",
            "pub_date": "2026-02-26 19:06:33",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557610",
            "title": "Sopra Steria Group SA GAAP EPS of €15.23, revenue of €5.64B",
            "description": "<html><body><ul>\n<li>Sopra Steria Group SA <a href=\"https://seekingalpha.com/pr/20414640-sopra-steria-group-2025-results\">press release</a> (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/SPSAF\" title=\"Sopra Steria Group SA\">SPSAF</a></span>): FY GAAP EPS of $15.23.</li>\n<li>Revenue of <span>€</span>5.64B.</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557610-sopra-steria-group-sa-gaap-eps-of-1523-revenue-of-564b",
            "pub_date": "2026-02-26 19:00:56",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557611",
            "title": "Getlink SE reports FY results",
            "description": "<html><body><ul>\n<li>Getlink SE <a href=\"https://seekingalpha.com/pr/20414644-getlink-se-annual-results-2025-ebitda-at-859-million-above-guidance-dividend-of-0_80-per\">press release</a> (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/GRPTF\" title=\"Getlink SE\">GRPTF</a></span>): FY Revenue of €1.59B.</li>\n<li><ul>\n<li>EBITDA: €859 million (+4% vs 2024), exceeding the top end of the guidance for 2025.</li>\n<li>Cash position<span> </span>at €1,498 million at 31 December 2025.</li>\n<li>Consolidated net profit of €320 million, up 3%.</li>\n<li>Proposed dividend of €0.80 per share, vs €0.58 per share in 2024.</li>\n</ul></li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557611-getlink-se-reports-fy-results",
            "pub_date": "2026-02-26 19:00:56",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557609",
            "title": "London Stock Exchange reports FY results",
            "description": "<html><body><ul>\n<li>London Stock Exchange <a href=\"https://www.lseg.com/content/dam/lseg/en_us/documents/investor-relations/financial-results/preliminary-results/rns/lseg-2025-preliminary-results-rns-26feb2026.pdf\" rel=\"nofollow\" target=\"_blank\">press release</a>  (LDNXF): FY Non-GAAP EPS of £420.6.</li>\n<li>Total income up 5.5% to £9.35B</li>\n<li>Organic constant currency growth in total income excluding recoveries of 6.5-7.5% including an acceleration in our subscription businesses’ organic growth</li>\n<li>An improvement in constant currency EBITDA margin of 80-100 basis points</li>\n<li>Capex intensity of c 9.5% of total income excluding recoveries</li>\n<li>Equity free cash flow of at least £2.7 billion, based on foreign exchange rates of £1 = $1.32 and €1.17</li>\n<li>Underlying effective tax rate of 24-25%</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557609-london-stock-exchange-reports-fy-results",
            "pub_date": "2026-02-26 18:55:45",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4557595",
            "title": "Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München reports FY results",
            "description": "<html><body><ul>\n<li>Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München <a href=\"https://www.munichre.com/en/company/media-relations/media-information-and-corporate-news/media-information/2026/media-release-2026-02-26.html\" rel=\"nofollow\" target=\"_blank\">press release</a>  (MURGY): FY Net result for 2025 financial year of €6.1bn, outperforms guidance by €0.1bn</li>\n<li>Dividend: Subject to approval by the Annual General Meeting, the dividend will increase to €24 per share</li>\n<li>New share buy-back with a higher volume of €2.25bn to be completed by 2027 Annual General Meeting</li>\n<li>Outlook: Net result for 2026 expected to rise to €6.3bn.</li>\n<li>\"2025 was a pivotal year for Munich Re. With a net result of €6.1bn, we not only set a new record, but also delivered on all the promises we had made as part of our five-year Ambition 2025 strategy programme. In times of crisis, our business model has proven to be resilient, growth-driven and profitable. Munich Re has consistently seized market opportunities as well as increased earnings while also stabilising them. This has allowed us to fully live up to the expectations of all stakeholders: our shareholders, customers, employees and society at large. Our new Ambition 2030 strategy programme will see us further diversify our business portfolio, expand the range of products and services we offer, and advance Munich Re as it evolves into a group that offers reinsurance, specialty insurance, and primary insurance at scale.\" said Christoph Jurecka Chair of the Board of Management.</li>\n</ul>\n<div class=\"signup_widget_placeholder\"></div>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4557595-munchener-ruckversicherungs-gesellschaft-aktiengesellschaft-in-munchen-reports-fy-results",
            "pub_date": "2026-02-26 18:50:35",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}